Insider Transactions in Q4 2023 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2023
|
Michel Detheux Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+33.74%
|
-
|
|
Dec 05
2023
|
Matthew Gall Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+40.42%
|
-
|
|
Dec 05
2023
|
Matthew Call Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+24.19%
|
-
|
|
Dec 05
2023
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+50.0%
|
-
|
|
Oct 12
2023
|
Matthew Gall Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+20.47%
|
$40,000
$8.37 P/Share
|